Differences between African Americans and whites in their attitudes toward genetic testing for Alzheimer's disease

Genetic Testing

Volumn 7, Issue 1, 2003, Pages 39-44

  Hipps, Yvonne G ^a   Roberts, J Scott ^b   Farrer, Lindsay A ^b   Green, Robert C ^b  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTITUDE; CONTROLLED STUDY; CULTURAL FACTOR; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MALE; NORMAL HUMAN; PREDICTION; PUBLIC OPINION; RACE DIFFERENCE;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

PIERINAE;

EID: 0037357846     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065703321560921     Document Type: Article

References (29)

1. ALMQVIST, E., BLOCH, M., BRINKMAN, R., CRAUFURD, D., and HAYDEN, M. (1999). A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am. J. Hum. Genet. 64, 293-1304.
2. BALLARD, E.L., NASH, F., RAIFORD, K., and HARRELL, L.E. (1993). Recruitment of black elderly for clinical research studies of dementia: The CERAD experience. Gerontologist 33, 561-565.
3. BECKER, M.H. (1974). The health belief model and personal health behavior [Monograph]. Health Ed. Monogr. 2, 324-473.
4. BROOKMEYER, R., GRAY, S., and KAWAS, C. (1998). Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health, 88, 1337-1342.
5. BROWN, T.C., LARUSSE, S.A., BARBER, M., FARRER, L.A., CUPPLES, L.A., POST, S.G., SADOVNICK, A.D., DAVIS, J.G., QUAID, K.A., WHITEHOUSE, P.J., RELKIN, N.R., and GREEN, R.C. (2000). The REVEAL study: A new model for susceptibility genotyping, risk assessment and counseling for Alzheimer disease. [Abstract] Am. J. Hum. Genet. 67(Suppl. 2), 62.
6. COON, D.W., DAVIES, H., MCKIBBEN, C., and GALLAGHERTHOMPSON, D. (1999). The psychological impact of genetic testing for Alzheimer disease. Genet. Testing, 3, 121-131.
7. CROYLE, R.T., and LERMAN, C. (1995). Psychological impact of genetic testing., In Psychosocial Effects of Screening for Disease Prevention and Detection R.T. Croyle (ed.). (Oxford University Press, New York) pp. 11-38.
8. GAUTHIER, M.A., and CLARKE, W.P. (1999). Gaining and sustaining minority participation in longitudinal research projects. Alzheimer Dis. Assoc. Disord. 13(suppl. 1), S29-S33.
9. GREEN, R.C. (2001). Diagnosis and Management of Alzheimer's Disease and Other Dementias. (Professional Communications, Caddo, OK).
10. GREEN, R.C., CLARKE, V.C., THOMPSON, N.J., WOODARD, J.L., and LETZ, R. (1997). Early detection of Alzheimer disease: methods, markers, and misgivings. Alzheimer Dis. Assoc. Disord. 11(suppl. 5), S1-S5.
11. GREEN, R.C., CUPPLES, L.A., GO, R., BENKE, K.S., EDEKI, T., GRIFFITH, P.A., WILLIAMS, M., HIPPS, Y., GRAFF-RADFORD, N., BACHMAN, D., and FARRER, L. (2002a). Risk of dementia among white and African American relatives of patients with Alzheimer disease. J. Am. Med. Assn. 287, 329-336.
12. GREEN, R.C., RELKIN, N., WHITEHOUSE, P.J., BROWN, T., LARUSSE, S., BARBER, M., and ROBERTS, J.S. (2002b). Among adult offspring of persons with Alzheimer's disease, who will elect to pursue risk assessment and APOE disclosure? Preliminary results from the REVEAL Study. [Abstract]. Neurology 58, A40.
13. GREEN, R.C. (2002c). Genetic susceptibility testing: Has the moment arrived? Alz. Care Quarterly 3, 208-214.
14. LARUSSE, S.A., RAVDIN, L.D., BROCKMAN, J., TSAI, J., DAVIS, J.G., GREEN, R.C., BROWN, T.B., and RELKIN N.R. (2000). Genetic testing for Alzheimer disease: Preliminary results of a protocol for presymptomatic APOE genotyping. [Abstract]. Am. J. Hum. Genet. 67(Suppl. 2), 204.
15. LAZARUS, R.S., and FOLKMAN, S. (1984). Stress, Appraisal, and Coping. (Springer, New York).
16. LENDON, C.L., ASHALL, F., and GOATE, A.M. (1997). Exploring the etiology of Alzheimer disease using molecular genetics. J. Am. Med. Assn. 277, 825-831.
17. LENNOX, A., KARLINSKY, H., MESCHINO, W., BUCHANAN, J.A., PERCY, M.E., and BERG, J.M. (1994). Molecular genetic predictive testing for Alzheimer's disease: Deliberations and preliminary recommendations. Alzheimer Dis. Assoc. Disord. 8, 126-147.
18. MASTERS, C.L., and BEYREUTHER, K. (1998). Science, medicine, and the future: Alzheimer's disease. Br. Med. J. 316, 446-448.
19. MCCONNELL, L.M., KOENIG, B.A., GREELY, H.T., RAFFIN, T.A., and the Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics, & Society. (1998). Genetic testing and Alzheimer disease: Has the time come? Nature Med. 4, 757-759.
20. NEUMANN, P.J., HAMMITT, J.K., MUELLER, C., FILLIT, H.M., HILL, J., TETTEH, N.A., and KOSIK, K.S. (2001). Public attitudes about genetic testing for Alzheimer's disease. Health Affairs 20, 252-264.
21. PETRIE, K.A., and WEINMAN, J.A., Eds. (1997). Perceptions of Health and Illness. (Harwood Academic Publishers, Amsterdam).
22. POST, S.G., WHITEHOUSE, P.J., BINSTOCK, R.H., BIRD, T.D., ECKERT, S.K., FARRER, L.A., FLECK, L.M., GAINES, A.D., JUENGST, E.T., KARLINSKY, H., MILES, S., MURRAY, T.H., QUAID, K.A., RELKIN, N.R., ROSES, A.D., ST. GEORGE-HYSLOP, P.H., SACHS, G.A., STEINBOCK, B., TRUSCHKE, E.F., and ZINN, A.B. (1997). The clinical introduction of genetic testing for Alzheimer disease: An ethical perspective. J. Am. Med. Assn. 277, 832-836.
23. POST, S.G., and WHITEHOUSE, P.J., Eds. (1998). Genetic Testing for Alzheimer Disease: Ethical and Clinical Issues. (Johns Hopkins University Press, Baltimore, MD).
24. QUAID, K.A. (1992). Presymptomatic testing for Huntington's disease: recommendations for counseling. J. Genet. Counseling 1, 277-302.
25. ROBERTS, J.S. (2000). Anticipating response to predictive genetic testing for Alzheimer's disease. Gerontologist 40, 43-52.
26. ROBERTS, J.S., CONNELL, C.M., CISEWSKI, D., HIPPS, Y.G., DEMISSIE, S., and GREEN, R.C. (2003). Differences in perceptions of Alzheimer's disease between African Americans and White Americans (2003). Alz. Dis. and Related Disorders, in press.
27. ROBERTS, S., RELKIN, N., WHITEHOUSE, P.J., BROWN, T., BARBER, M., LARUSSE, S., and GREEN, R.C. (2002). Reasons for pursuing genetic susceptibility testing for Alzheimer's disease: Preliminary findings from the REVEAL Study. Neurology 58, A41.
28. ROSES, A.D. (1997). Genetic testing for Alzheimer disease: Practical and ethical issues. Arch. Neurology 54, 1226-1229.
29. TAMBOR, E.S., BERNHARDT, B.A., CHASE, G.A., FADEN, R.R., GELLER, G., HOFMAN, K.J., and HOLTZMAN, N.A. (1994). Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization. Am. J. Hum. Genet. 55, 626-637.